Reata Pharmaceuticals (RETA) Stock Highlights

172.36 | +0%

2023-10-25 23:29:27

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The companys product in the pipeline include bardoxolone methyl; Omaveloxolone and others.

Statistics

Range Today

172.36 172.36

Volume Today 0

Range 1 Year

21.83 172.46

Volume 1 Year 245.84M

Range 3 Year

18.47 186.817

Volume 3 Year 503.41M

Range 10 Year

11.03 257.965

Volume 10 Year 777.3M

Highlights

Market Capitalization 4.11B (mid)

Floating Shares 26.73M

Current Price 172.36

Price To Earnings -10.83

Price To Revenue 2.55K

Earnings Per Share -9.92

Payout Ratio 0%

Performance

Latest 0%

1 Month +1.92%

3 Months +88.29%

6 Months +96.24%

1 Year +635.32%

3 Years +82.28%

5 Years +104.29%

10 Years +1458.41%

Benchmarks

Market Capitalization

42 / 368

Gross Profits

259 / 278

Total Revenue

227 / 300

Total Rank

352 / 368

Free Cashflow

312 / 352

Performance 5 years

72 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.